Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Neutral
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.2.9289.4699
Address
Level 3 120 Sussex Street Sydney, New South Wales (NSW) 2000
Description
PharmX Technologies Ltd. engages in the research and development of software solutions. It operates through the Health Services and eCommerce segment. The Health Services segment provides dispense and point of sale software applications, along with hardware and support services to Australian pharmacies. The eCommerce segment offers individuals and businesses the opportunity to pay their rent, utilities, local government fees, and commercial obligations via electronic methodologies. The company was founded in 1950 and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.01 - 0.06
Trade Value (12mth)
AU$3,675.00
1 week
17.5%
1 month
4.44%
YTD
30.56%
1 year
32.13%
All time high
0.63
EPS 3 yr Growth
-215.00%
EBITDA Margin
23.50%
Operating Cashflow
$3m
Free Cash Flow Return
16.70%
ROIC
0.50%
Interest Coverage
35.40
Quick Ratio
1.40
Shares on Issue (Fully Dilluted)
599m
HALO Sector
Technology
Next Company Report Date
01-Sep-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
03 September 24 |
Corporate Governance Statement and Appendix 4G
×
Corporate Governance Statement and Appendix 4G |
27 August 24 |
2024 Annual Report and Appendix 4E
×
2024 Annual Report and Appendix 4E |
27 August 24 |
FY24 Results
×
FY24 Results |
27 August 24 |
Investor Presentation
×
Investor Presentation |
16 August 24 |
Delay of Results Announcement
×
Delay of Results Announcement |
09 August 24 |
Update on Fred Appeals in Legal Proceedings
×
Update on Fred Appeals in Legal Proceedings |
09 August 24 |
Letter to Shareholders
×
Letter to Shareholders |
08 August 24 |
Trading Halt
×
Trading Halt |
06 August 24 |
Update Fred Appeal legal proceedings re Corum Systems/PharmX
×
Update Fred Appeal legal proceedings re Corum Systems/PharmX |
31 July 24 |
Ceasing to be a substantial shareholder from AEF
×
Ceasing to be a substantial shareholder from AEF |
30 July 24 |
Change in substantial shareholding from AEF
×
Change in substantial shareholding from AEF |
24 July 24 |
Notice of Results Announcement 30 June 2024
×
Notice of Results Announcement 30 June 2024 |
18 July 24 |
ATO confirms tax implications of return of share capital
×
ATO confirms tax implications of return of share capital |
30 May 24 |
Update on Fred Appeals in Legal Proceedings
×
Update on Fred Appeals in Legal Proceedings |
01 March 24 |
Notification regarding unquoted securities - PHX
×
Notification regarding unquoted securities - PHX |
23 February 24 |
Appendix 4D and HY Report for 31 Dec 2023
×
Appendix 4D and HY Report for 31 Dec 2023 |
23 February 24 |
Results for the HY ended 31 Dec 2023
×
Results for the HY ended 31 Dec 2023 |
23 February 24 |
Investor Presentation
×
Investor Presentation |
22 February 24 |
Appointment of Interim CFO and change of Company Secretary
×
Appointment of Interim CFO and change of Company Secretary |
16 February 24 |
Change of Director's Interest Notice - N England
×
Change of Director's Interest Notice - N England |
14 February 24 |
Notice of Results Announcement
×
Notice of Results Announcement |
12 February 24 |
Response to ASX Price Query
×
Response to ASX Price Query |
05 December 23 |
Capital Return Confirmation
×
Capital Return Confirmation |
22 November 23 |
Return of Capital - PHX
×
Return of Capital - PHX |
21 November 23 |
Chair's Address to Shareholders
×
Chair's Address to Shareholders |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.